It is a single arm clinical study to see the efficacy of Darvyadi Kwath drug (Ayurvedic formulation)in patients suffering from neuropathic symptoms caused due to chronocity of Diabetes Mellitus disease.

A Single Arm clinical study to evaluate the efficacy of Darvyadi Kwath in Diabetic Polyneuropathy. - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065793

Enrollment

Registered

2024-04-16

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: A known Diabetic on treatment. Patient who are not taking any medications for Diabetic Polyneuropathy And having symptoms of Diabetic Polyneuropathy

Exclusion criteria

Exclusion criteria: 1. Pregnant lactating women. 2. Patients with pulmonary tuberculosis, cardiac complications, Renal complications, sciatica, cord compression, Immunocompromised patients, malignancies. 3. Vitamin B12 deficiency.

Design outcomes

Primary

Measure	Time frame
efficacy of Darvyadi Kwath will be assessed over the 28 days by objective parameters.Timepoint: 28 Days study. Follow up on 14th and 28th days	—

Secondary

Measure	Time frame
To study the Distal Symmetric Polyneuropathy in Diabetes under the subjective measurement of Toronto Clinical scoring scale.Timepoint: 28 Days study. Follow up on 14th & 28th day.	—

Countries

India

Contacts

Public ContactDr Abhijit Shekhar

Dr. D. Y. Patil College of Ayurved and Research Centre

abhijitshekhar00@gmail.com9168448887

Outcome results